Community pharmacists can play an important role in diabetes management by providing education, monitoring medication adherence, and supporting self-monitoring of blood glucose. As accessible healthcare providers, pharmacists can help interpret blood glucose data, assist with treatment adjustments, and facilitate study circles or educational programs to help patients better manage their condition. While establishing comprehensive diabetes management programs presents challenges, systematically involved pharmacists could help reduce complications and healthcare costs by improving patient care and outcomes.
Chapter 7_Health Screening Services in Community Pharmacy.pptxVinayGaikwad14
Introduction,
Scope and importance of various health screening services - for routine monitoring of patients,
Early detection,
And referral of undiagnosed cases
Chapter 7_Health Screening Services in Community Pharmacy.pptxVinayGaikwad14
Introduction,
Scope and importance of various health screening services - for routine monitoring of patients,
Early detection,
And referral of undiagnosed cases
Use of computers in hospital pharmacy, biostatistics and research methodology...shaistasumayya2
Computers in pharmacy are used for the information of drug data, records and files, drug management (creating, modifying, adding and deleting data in patient files to generate reports), business details.
Introduction to daily activities of clinical pharmacist.
Drug therapy monitoring,
Medication chart review
Clinical Progress
Pharmacist intervention
Detection and management of ADRs
A concise overview of pharmacoeconomics, health economics, various costs, various pharmacoeconomic study designs and its application in the field of medicine and drug development
REVIEWING THE CLINICIANS PRESCRIPTION AND TREATMENT PROGRESSION IS THE FUNDAMENTAL RESPONSIBILITY OF PHARMACIST. THIS PRESENTATION WILL DEAL WITH VARIOUS ASPECTS OF REVIEWING PATIENT DRUGTHERAPY PLAN
Pharmacoeconomics is a branch of health economics which compares the value of one drug or a drug therapy to another.
By understanding the principles, methods, and application of pharmacoeconomics, healthcare professionals will be prepared to make better decisions regarding the use of pharmaceutical products and services.
• Introduction
• The main activities of community pharmacists
• Processing of prescriptions
• Care of patients or clinical pharmacy
• Extemporaneous preparation and small-scale manufacture of medicines
• Traditional and alternative medicines
• Monitoring of drug utilization
• Responding to symptoms of minor ailments
• Informing health care professionals and the public
• Health promotion
• Domiciliary services
• Rational Use of Drugs
• Individualization of Drug
• Community Pharmacists Play Key Role in Improving Medication Safety
• Pharmacists as a Community Resource
• Conclusion
Use of computers in hospital pharmacy, biostatistics and research methodology...shaistasumayya2
Computers in pharmacy are used for the information of drug data, records and files, drug management (creating, modifying, adding and deleting data in patient files to generate reports), business details.
Introduction to daily activities of clinical pharmacist.
Drug therapy monitoring,
Medication chart review
Clinical Progress
Pharmacist intervention
Detection and management of ADRs
A concise overview of pharmacoeconomics, health economics, various costs, various pharmacoeconomic study designs and its application in the field of medicine and drug development
REVIEWING THE CLINICIANS PRESCRIPTION AND TREATMENT PROGRESSION IS THE FUNDAMENTAL RESPONSIBILITY OF PHARMACIST. THIS PRESENTATION WILL DEAL WITH VARIOUS ASPECTS OF REVIEWING PATIENT DRUGTHERAPY PLAN
Pharmacoeconomics is a branch of health economics which compares the value of one drug or a drug therapy to another.
By understanding the principles, methods, and application of pharmacoeconomics, healthcare professionals will be prepared to make better decisions regarding the use of pharmaceutical products and services.
• Introduction
• The main activities of community pharmacists
• Processing of prescriptions
• Care of patients or clinical pharmacy
• Extemporaneous preparation and small-scale manufacture of medicines
• Traditional and alternative medicines
• Monitoring of drug utilization
• Responding to symptoms of minor ailments
• Informing health care professionals and the public
• Health promotion
• Domiciliary services
• Rational Use of Drugs
• Individualization of Drug
• Community Pharmacists Play Key Role in Improving Medication Safety
• Pharmacists as a Community Resource
• Conclusion
Pharmacist role in the community and new aspects of pharmacy professionNabil El-Hady
my lecture with my young SAMPSian friends
"Pharmacist role in the community "
In a prepration to a huge campaign aiming to raise the people apperception and to correct some wrong conception about pharmacists
Role of pharmacist in managing diabetes mellitusSomnath Das
As a healthcare professional like a pharmacist we can deliver a very good quality of healthcare services to the common people. Here I have spoke to you about the possibilities of a pharmacist in controlling a chronic disease like diabetes mellitus. I have clearly mentioned the process of controlling such disease through simple slides. I hope all of you will get some help from it. Thank you.
Team as Treatment: Driving Improvement in DiabetesCHC Connecticut
NCA Clinical Workforce Development, Team-Based Care 2019 Webinar Series
Webinar broadcast on: June 11, 2019 | 3 p.m. EST
This webinar will share evidence-based models that will provide a framework for health centers to optimize the team in primary care. Experts will describe how utilization of extended team members and technology can reduce gaps in care for prediabetics and diabetics. With a focus on lifestyle and community based projects, this webinar will highlight the strategies and resources to improve the health and behaviors of patients at risk for diabetes and manage uncontrolled diabetes. Through early detection and providing diabetes management through a team-based care, health centers can help patients’ live long, healthy lives.
Healthcare Perceptions of Injectable Therapies for Diabetes Mellitus Type 2CrimsonPublishersIOD
Diabetes mellitus is considered a global epidemic, with financial impacts beyond the cost of treatment. Multiple treatment options are available;
however, many healthcare providers lack knowledge or face perceived barriers to prescription. While the American Diabetes Association publishes
yearly guideline updates for the management and care of diabetes, many health care providers are unfamiliar with these guidelines. These guidelines
recommend insulin and other inject able therapies early in the disease progression, yet the DAWN study demonstrated that physicians delay the initiation
of insulin therapy. This paper will review the knowledge gaps, health care provider barriers, and perceptions of inject able therapies. From this review,
more knowledge is needed by prescribers in the initiation and management of injectable therapies to help patients successfully reach glycemic targets.
The learning outcome for this activity: Participants will have increased knowledge of using the Age-Friendly 4Ms Framework while caring for an older adult patient with Diabetes Mellitus in a convenient care setting.
Similar to Role of community pharmacists in diabetes management (20)
This is part two of the diabetes presentation aimed for pharmacists and allied health professional who are interested in tailoring special pharmaceutical care plans for diabetic patients.
Many have troubles choosing the proper insulin type and dosing for their patients.. Here is a quick presentation that introduce you to different studies in that matter.
This presentation is intended for healthcare prfessionals
This presentation is intended to allied health professional to have a overview of different types of insulin. It is meant to be a memory refresh. It was presented as part of continuing medical education session
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
2. • A pharmacist is one of few medical professionals in the
world to whom a patient or anyone else can go for a
consultation or advice without an appointment.
• They are knowledgeable about a myriad of aspects
concerning patients and their medication.
• It is thus of the utmost importance to take these skills
into consideration when it comes to diabetic
education.
• Pharmacists have long-term relationships with most of
their chronic patients, which sets a good foundation for
mutual trust and respect and better patient
compliance.
11/15/2013
2
The role of community pharmacist in diabetes management
Strengths of community pharmacist
3. Provider of
healthcare
education
Provider of
pharmaceutical care
Formulator,
distributor,
and
compounder
11/15/2013
Provider of
costeffective
therapy
Provider of
essential
care
services
Advisor on
the safe and
rational use
of meds
3
The role of community pharmacist in diabetes management
Pharmacy is a dynamic, information
driven, patient-orientated profession
4. The role of community pharmacist in diabetes management
•
•
•
Wild S et al. Diabetes Care 2004;27:1047–53.
Diabetes and disease state
management
An escalating epidemic with predictions of
worldwide prevalence exceeding three million by
2030.
Strict control of type 2 diabetes can delay the
onset of the complications of this disease is costeffective, and brings about improvements in
overall quality of life.
Disease state management (DSM)
approaches focus on intensive
management of type 2 diabetes
involving regular monitoring, followup, and continuity
of care.
11/15/2013
4
5. The role of community pharmacist in diabetes management
Pharmacist’s role in diabetes DSM
Pharmacists are ideally placed to contribute to DSM
programs and assist in the detection, education and
referral of individuals at risk of diabetes.
•
•
•
•
•
•
•
Support of self blood glucose monitoring (SBGM)
Monitor & promote patient adherence
Identify and resolving drug-related problems
Provide targeted education
Monitor blood pressure, weight
and lipids
Remind patients of the
importance of regular exams
A disease management educator
and tutor
11/15/2013
5
6. A small group of people interested in the same subject
invite lecturers, and had discussions.
The aim is to gain knowledge that does not only include facts
but change ones existence.
Knowledge should be sought by group members in texts as
well as from their own experiences.
The long-term goal of an SC for diabetes should be to develop
a diabetes education program to teach glucose control and
help participants cope with their diabetes.
The pharmacy is a good setting since it is a widely distributed
service.
11/15/2013
6
Clifford RM et al.Int J Pharm Pract 2002;10:85–9.
The role of community pharmacist in diabetes management
Study circles
7. Pharmacists should be trained
to promote learning and be
able to handle conflict that
might arise out of group
discussions. For some it can
be hard in the beginning to
abstain from lecturing and let
the group do the work and it
is therefore imperative that
some knowledge of group
dynamics is present.
11/15/2013
7
The role of community pharmacist in diabetes management
Pharmacist as a SC facilitator
8. The role of community pharmacist in diabetes management
Effective disease state management
The key to effective diabetes management is
the adoption of a systematic approach of:
• Collecting
• Interpreting, and
• Acting on blood glucose data.
11/15/2013
Berringer R. et al. J Am Pharm Assoc 1999;39:791–7.
8
9. The role of community pharmacist in diabetes management
Collection
Glucose profiling has consistently been
associated with improved glycemic control,
whether evaluated as part of an intensive
insulin management strategy or as a component
of management of patients not treated with
insulin.
Intensive insulin therapy guided by SMBG
performed at least four times per day was
associated with a > 2.0% reduction in
HbA1c.
Similar findings were observed in patients
with type-2 diabetes
11/15/2013
9
10. • Handwritten logbooks can be incomplete, inaccurate, and
illegible faulty analyses of BG trends
• The use of data-management software may help both
patients and health care professionals manage these profiles
and achieve glycaemic control.
• A free online software provides text and graphic
presentations of downloaded data.
This may:
11/15/2013
• help in the management of patients’ diabetes
• increase their knowledge of diabetes
• increase SMBG frequency
• improve overall glycaemic control
• increase patients’ satisfaction with their care
• be cost effective
http://software.ascencia.com
10
The role of community pharmacist in diabetes management
Interpretation
11. The role of community pharmacist in diabetes management
Action
• Base on systematic approach of pre- and postmeal targets
• Management plan can be reassessed depending on changing
glucose readings
• Recognizing patterns and implement changes is critical.
• Systematic use of glucose profiles improves glycaemic control
• SMBG data be accurately
obtained and reviewed.
• Patient education may facilitate
adherence to appropriate
treatment regimens and
improveoutcomes.
11/15/2013
11
12. The role of community pharmacist in diabetes management
Ideal diabetes care program
• Based on national standards for
diabetes self-management
education programs-Life with
Diabetes
• Pharmaceutical care + Education +
Nutrition
• Multidisciplinary program/
Dietitian
• Advisory Board that oversees the
Program
11/15/2013
12
14. The role of community pharmacist in diabetes management
Session outcomes
Improvement in Clinical Markers
• Blood glucose, HbA1c, BP, weight, etc.
Improvement in patient’s quality of life
Improvement in patient’s knowledge of the
disease
Patient’s satisfaction with the services
Decrease in overall health care cost,
hospitalizations, ER visits and complications
of diabetes
11/15/2013
Krass I. et al. Diabet Med 2007;24:677–83.
14
15. The role of community pharmacist in diabetes management
Challenges
• Breaking new grounds
• Slow Process
–
–
–
–
11/15/2013
Recognition Process
Reimbursement
Pharmacist Training
Marketing
Krass I. et al. Diabet Med 2007;24:677–83.
15
16. • Pharmacists could, in fact, play a more active role
in quality diabetes care.
• Systematically educated pharmacists could
perform group education for diabetes patients,
thus easing the burden on the primary health
care centers and giving participants the time they
need.
• Mutual respect between medical professionals
and the pharmacist for each other’s competence
could lead to a well functioning system for all
parties involved.
11/15/2013
16
The role of community pharmacist in diabetes management
Sum-up
17. The role of community pharmacist in diabetes management
The Community Pharmacist’s Role in Diabetes Management
CE program for pharmacists
Anas Bahnassi PhD CDM CDE
abahnassi@gmail.com
http://www.twitter.com/abpharm
http://www.facebook.com/pharmaprof
http://www.linkedin.com/in/abahnassi
11/15/2013
17